Search > Skin Cancer
My employer runs this trial

mHealth Interventions for Skin Cancer

(SESAME Trial)

Not yet recruiting at 1 trial location
NA
BN
Overseen ByBonnie Nolan
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Northwestern University
Disqualifiers: Medical condition preventing MVPA, others
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to evaluate 5 different smartphone administered sun protection interventions that aim to reduce unprotected sun exposure in melanoma survivors. Participants are asked to wear an ultraviolet (UV) device and an activity monitor (Actigraph) to measure their daily UV exposure and track their physical activity for three separate assessment weeks and complete daily surveys. After the first assessment week, eligible participants are assigned up to 5 different sun protection interventions that are administered through a smartphone application for 8 weeks. Following 8-week use of the sun protection interventions, participants complete another assessment week. At the end of the assessment week, participants provide feedback on the design and usability of the UV device, smartphone application and each of the sun protection interventions that they experienced. One year later, participants are contacted again to complete a final assessment week.

Who Is on the Research Team?

NA

Nabil Alshurafa, PhD

Principal Investigator

Northwestern University

TS

Tammy Stump, PhD

Principal Investigator

Huntsman Cancer Institute at The University of Utah

Are You a Good Fit for This Trial?

Inclusion Criteria

Is able to speak, read and write in English
I was diagnosed with melanoma and have not had treatment for it in the past three months.
I am willing to download and use a study app.
See 5 more

Exclusion Criteria

I have a condition or doctor's advice that prevents me from doing moderate exercise.
Is currently enrolled in another study on MVPA

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (virtual)

Baseline Assessment

Participants wear UV and activity monitors and complete daily surveys for the first assessment week

1 week
Daily monitoring (remote)

Intervention

Participants receive up to 5 different sun protection interventions via a smartphone app

8 weeks
Remote engagement through app

Post-Intervention Assessment

Participants complete another assessment week and provide feedback on interventions

1 week
Daily monitoring (remote)

Follow-up

Participants are contacted one year later to complete a final assessment week

1 week
Daily monitoring (remote)

What Are the Treatments Tested in This Trial?

Interventions

  • Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

How Is the Trial Designed?

32

Treatment groups

Experimental Treatment

Group I: Experimental Condition 9Experimental Treatment5 Interventions
Group II: Experimental Condition 8Experimental Treatment3 Interventions
Group III: Experimental Condition 7Experimental Treatment4 Interventions
Group IV: Experimental Condition 6Experimental Treatment4 Interventions
Group V: Experimental Condition 5Experimental Treatment5 Interventions
Group VI: Experimental Condition 4Experimental Treatment4 Interventions
Group VII: Experimental Condition 32Experimental Treatment1 Intervention
Group VIII: Experimental Condition 31Experimental Treatment2 Interventions
Group IX: Experimental Condition 30Experimental Treatment2 Interventions
Group X: Experimental Condition 3Experimental Treatment5 Interventions
Group XI: Experimental Condition 29Experimental Treatment3 Interventions
Group XII: Experimental Condition 28Experimental Treatment2 Interventions
Group XIII: Experimental Condition 27Experimental Treatment3 Interventions
Group XIV: Experimental Condition 26Experimental Treatment3 Interventions
Group XV: Experimental Condition 25Experimental Treatment4 Interventions
Group XVI: Experimental Condition 24Experimental Treatment2 Interventions
Group XVII: Experimental Condition 23Experimental Treatment3 Interventions
Group XVIII: Experimental Condition 22Experimental Treatment3 Interventions
Group XIX: Experimental Condition 21Experimental Treatment4 Interventions
Group XX: Experimental Condition 20Experimental Treatment3 Interventions
Group XXI: Experimental Condition 2Experimental Treatment5 Interventions
Group XXII: Experimental Condition 19Experimental Treatment4 Interventions
Group XXIII: Experimental Condition 18Experimental Treatment4 Interventions
Group XXIV: Experimental Condition 17Experimental Treatment5 Interventions
Group XXV: Experimental Condition 16Experimental Treatment2 Interventions
Group XXVI: Experimental Condition 15Experimental Treatment3 Interventions
Group XXVII: Experimental Condition 14Experimental Treatment3 Interventions
Group XXVIII: Experimental Condition 13Experimental Treatment4 Interventions
Group XXIX: Experimental Condition 12Experimental Treatment3 Interventions
Group XXX: Experimental Condition 11Experimental Treatment4 Interventions
Group XXXI: Experimental Condition 10Experimental Treatment4 Interventions
Group XXXII: Experimental Condition 1Experimental Treatment6 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Huntsman Cancer Institute/ University of Utah

Collaborator

Trials
2
Recruited
3,400+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.